ArticleFrontiers in endocrinology2025
Noninvasive prediction of T-score in IgA nephropathy using machine learning within the Oxford classification system.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide. However, studies utilizing computed tomography (CT) to evaluate the severity of renal interstitial fibrosis in IgAN remain scarce. Objective: To explore the feasibility and value of combining pretreatment abdominal CT radiomics features with clinical characteristics and machine learning algorithms to determine the Oxford classification T score(renal interstitial fibrosis) of patients with IgAN. Methods: This retrospective study included 343 patients with IgAN from the First Affiliated Hospital of Zhengzhou University, confirmed by renal biopsy, pretreatment abdominal CT, and clinical data. The patients were divided into training (n = 240) and testing (n = 103) cohorts in a 7:3 ratio. Two senior radiologists delineated the regions of interest, and radiomic features were extracted from the CT images. The extracted radiomic attributes were subjected to least absolute shrinkage and selection operator (LASSO) regression with ten-fold cross-validation, thereby identifying a parsimonious subset of high-weighted imaging biomarkers that confer maximal discriminative power for the prediction of renal interstitial fibrosis. Based on clinical features, radiomic features, or a combination of both, random forest algorithms were employed to construct three-class discrimination models for the Oxford classification T-score of patients with IgAN. The diagnostic performance of the models was evaluated using receiver operating characteristic curves. Results: After feature selection, 26 radiomics features demonstrated predictive efficacy in diagnosing the T-score and were used to establish the radiomics model. The clinical radiomic model exhibited the best diagnostic performance. To diagnose patients with IgAN of Oxford classification T0, the model achieved an area under the curve (AUC) of 0.94 in the training cohort and 0.94 in the testing cohort. For T1 classification, the AUC was 0.97 in the training and 0.96 in the testing cohorts. For T2 classification, the AUC was 0.94 and 0.95 in the training and testing cohorts, respectively. Conclusions: The classification diagnostic model based on CT radiomics and clinical features combined with machine learning can accurately predict the Oxford classification T-score in patients with IgAN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.